PUMA BIOTECHNOLOGY, INC.: operating_income
| Value | {"amount": -39045000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2019-01-01 – 2019-12-31 |
| Status | current |
| Entity | PUMA BIOTECHNOLOGY, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:37:34.551981+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/25112303-38cb-4f27-ae3a-db58d05b33c1
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-21-009840Retrieved: 2026-08-19T13:37:34.551981+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001401667/operating-income/2019-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/25112303-38cb-4f27-ae3a-db58d05b33c1
History
- supersedes {"amount": -39098000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} (evidence 0001564590-20-007591)